Oxidative stress and abnormal cholesterol metabolism in patients with post-cardiac arrest syndrome

Midori Nagase1, Atsushi Sakurai2, Atsunori Sugita2

  • 1School of Bioscience and Biotechnology, Tokyo University of Technology, 1404-1 Katakura-cho, Hachioji, Tokyo 192-0982, Japan.

Insights

Post-cardiac arrest syndrome (PCAS) patients exhibit increased oxidative stress and liver dysfunction, impacting survival. Therapeutic hypothermia may improve coenzyme Q10 levels in PCAS patients.

Area of Science:

  • Biochemistry
  • Cardiology
  • Critical Care Medicine

Background:

  • Post-cardiac arrest syndrome (PCAS) involves whole-body ischemia/reperfusion injury.
  • Oxidative stress and tissue damage are significant concerns in PCAS patients.

Purpose of the Study:

  • To investigate biochemical markers of oxidative stress and liver function in PCAS patients.
  • To correlate these markers with patient outcomes and the effects of therapeutic hypothermia.

Main Methods:

  • Assessed coenzyme Q10 oxidation, plasma free fatty acids (FFA), and cholesterol metabolism (free cholesterol/cholesterol esters ratio).
  • Compared biochemical parameters in PCAS patients (n=40) versus healthy controls (n=55).
  • Analyzed time-course changes in relation to patient survival and therapeutic hypothermia.

Main Results:

  • PCAS patients showed increased oxidized coenzyme Q10, elevated FFA, and altered polyunsaturated fatty acid levels.
  • A significantly increased free cholesterol/cholesterol esters ratio suggested impaired lecithin-cholesterol acyltransferase activity.
  • Rapid declines in cholesterol esters were observed in non-survivors, indicating liver dysfunction's role in mortality.
  • Therapeutic hypothermia enhanced the plasma coenzyme Q10 to total cholesterol ratio.

Conclusions:

  • Liver function is a critical determinant of survival in post-cardiac arrest syndrome.
  • Biochemical markers like coenzyme Q10 and cholesterol metabolism reflect disease severity and prognosis.
  • Therapeutic hypothermia shows potential benefits in improving metabolic profiles in PCAS patients.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
489
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
670
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
318
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
316
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.2K